Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical describe TLR7 agonists

Aug. 16, 2018

Nuclear receptor ROR-gamma inverse agonists discovered at Genfit

Aug. 16, 2018

Shanghai Longwood Biopharmaceuticals identifies hepatitis B caspid assembly inhibitors

Aug. 16, 2018

Proteasome inhibitors patented by Chengdu Origin Biotechnology

Aug. 16, 2018

Hefei Institutes of Physical Sciences divulges EZH2 inhibitors

Aug. 16, 2018

Sunshine Lake Pharma presents acetyl-CoA carboxylase inhibitors

Aug. 14, 2018

REVOLUTION Medicines discovers SHP-2 inhibitors

Aug. 14, 2018

New Janus kinase inhibitors synthesized at Leo Pharma

Aug. 14, 2018

Council of Scientific and Industrial Research divulges caerulomycin A analogues

Aug. 14, 2018

Liverpool School of Tropical Medicine and collaborators patent compounds for filariasis

Aug. 14, 2018

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...